ArticleCancer management and research2026
Serum NGAL and G-CSFR as Predictive and Prognostic Biomarkers for Trastuzumab-Based Therapy in HER2-Positive Gastric Cancer: A Retrospective Study.
Jingwen Ying et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.